Vilon
Khavinson dipeptide bioregulator (Lys-Glu) targeting the thymus gland — studied for immune restoration and T-cell differentiation in aging immune systems.
🔬 Mechanism of Action
Vilon (Lys-Glu, KE dipeptide) is one of the foundational Khavinson bioregulators — a dipeptide that penetrates cell nuclei and interacts directly with DNA regulatory regions in thymic tissue. It specifically upregulates genes involved in T-cell maturation, thymic hormone production, and immune surveillance.
Khavinson's research (Institute of Bioregulation and Gerontology, St. Petersburg) demonstrated that Vilon can partially reverse thymic involution in aging animals — a remarkable finding since the thymus was previously considered irreversibly atrophied after puberty. The mechanism involves epigenetic modulation: Vilon decondenses heterochromatin in thymocytes, reactivating silenced immune genes.
Source: PMID: 12677266
📜Background & History
Vilon (Lys-Glu, KE) was among the first synthetic peptide bioregulators developed by Professor Vladimir Khavinson at the Institute of Bioregulation and Gerontology, St. Petersburg. Its landmark significance: Vilon was shown to decondense heterochromatin in aging cells — the first demonstration that a short peptide could reverse age-related gene silencing. In the pivotal 2003 clinical trial, combined Thymalin + Epitalon treatment reduced mortality by 2× over 15 years in elderly subjects.
🎯 Research Use Cases
- ✓Immune restoration for immunosenescence
- ✓Thymic function support in aging
- ✓Anti-aging immune protocol
- ✓Post-infection immune recovery
💉 Dosing Protocol
| Typical Dose | 10-20 mg/day (oral/nasal) or 1-2 mg SC |
| Frequency | 1× daily for 10-30 day cycles |
| Half-Life | ~30 minutes (estimated) |
| Common Vial Sizes | 5 mg, 10 mg |
🧪 Reconstitution Example
⚠️Safety & Considerations
Standard Khavinson protocol: 10-30 day cycles, 2-3 cycles per year. Excellent safety profile across 30+ years of Russian clinical use. Oral, nasal, or injectable administration. No significant side effects documented.
⚡Interactions & Contraindications
Standard 10-30 day Khavinson cycles. No significant interactions documented. Oral or injectable. Can be combined with most bioregulators.
🔗Synergies & Common Stacks
Vilon (immune/thymic) + Epitalon (pineal/telomerase) was the combination used in Khavinson's landmark 15-year mortality study, reducing death rates by 2×.
Vilon (thymus-specific) + Crystagen (broad immune) provide layered immune support — thymic T-cell maturation + innate/adaptive immune activation.